An Inherited Disorder of Lymphocyte Apoptosis: The Autoimmune Lymphoproliferative Syndrome
-
Figure 1. Frontal view of National Institutes of Health patient 2. (Reproduced with permission from Sneller and colleagues
.) Lymph node from patient 2 showing follicular hyperplasia and plasmacytosis (hematoxylin and eosin). (Courtesy of Dr. Elaine
Jaffe.) Immunohistochemical stain of patient 2's lymph node for cells showing lymphocyte surface marker CD3. (Courtesy of
Dr. Elaine Jaffe.) Immunohistochemical stain of patient 2's lymph node for cells showing lymphocyte surface marker CD4. (Courtesy
of Dr. Elaine Jaffe.) Immunohistochemical stain of patient 2's lymph node for cells showing lymphocyte surface marker CD8.
Few of the cells that stain reddish brown for CD3 are CD4 or CD8 . (Courtesy of Dr. Elaine Jaffe.) Computed tomographic scan
through the upper thorax and axillae and abdomen of patient 23 showing marked paratracheal, anterior mediastinal, and axillary
adenopathy. (Courtesy of Dr. Nilo Avila.) Computed tomographic scan through the upper thorax and axillae and abdomen of patient
23 showing hepatosplenomegaly. (Courtesy of Dr. Nilo Avila.) For panels B to E, original magnifications were ×200. For panels
C to E, the stain used was immunoperoxidase. Clinical, radiologic, and histologic features of patients with the autoimmune lymphoproliferative syndrome. A.[6]B.C.D.E.++F.G.
-
Figure 2. Spanning the cell membrane are Fas (CD95) and tumor necrosis factor 1 ( ) molecules. Each functions in homotrimers
to bind ligands (Fas ligand and TNF, respectively) and trigger apoptosis. Cytoplasmic adapter molecules (FADD/MORT-1) bind
the similar death domains of each receptor and then form complexes with caspase 8, which is cleaved to activate other caspase
enzymes that ultimately mediate degradation of cellular DNA, cell death, and disintegration. FADD = Fas-associated death domain
protein; FLICE/MACH 1 = FADD-like interleukin-1-converting enzyme/mediator of receptor-induced toxicity 1; NF-κB = nuclear
factor-κB; RIP = receptor interacting protein; TRADD = TNF receptor-associated death domain protein; TRAF 2 = TNF receptor-associated
factor 2. Mediators of lymphocyte apoptosis.TNFR1
-
Figure 3. Cell loss is the fraction of cycling T cells lost after 24 hours of Fas cross-linking by an agonistic monoclonal
antibody. Shown are the results obtained by using cycling T cells from normal controls ( ) and seven unrelated patients with
ALPS ( ). Apoptosis after Fas (CD95) stimulation is impaired in patients with the autoimmune lymphoproliferative syndrome (ALPS).NormPt
-
Figure 4. The gray boxes covering exons 2 through 5 correspond to the extracellular cysteine-rich receptor domains ( ). The
dark area of exon 9 is the cytoplasmic death-signaling domain. The localization and type of mutations in patients with the
autoimmune lymphoproliferative syndrome are depicted above the exon drawing. The top line of symbols identifies the location
of all published mutations from other research centers, including those in Italy ( ) and France ( ). The lower line of symbols
depicts the mutations identified in National Institutes of Health patients. All of the mutations to date are single-nucleotide
changes except for the 290-base pair ( ) homozygous deletion in exon 9 (Fr) found in a severely affected daughter of related
parents . The region of the gene most often mutated is the intracellular death domain. The organization of theAPT1gene encoding Fas (CD95) (shown as numbered boxes separated by slashed lines indicating the intron
sequences).CRDsItFrbp(2)APT1
-
Figure 5. A spectrum of clinical presentations is seen among the affected family members; some exhibit lymphoproliferation,
increased double-negative T cells, and autoimmunity. One member developed lymphoma. The squares represent males; the circles
represent females; the arrow identifies the proband; and the slash identifies a family member who died. Reproduced with permission
from Infante and colleagues . A kindred of 11 persons in four generations with a mutation in the death domain of Fas.(8)
-
Figure 6. In normal persons, B-cell ( ) and T-cell ( ) precursors undergo development under conditions that lead to the elimination
of self-reactive cells. In the context of antigen stimulation, the mature B and T cells that emerge intact from this process
interact through CD40/CD40L, and the B cells differentiate into antibody-producing cells ( ). As a further safeguard against
the development of self-reactive cells, the latter are susceptible to Fas-mediated apoptosis unless they are co-stimulated
by specific antigen. Interleukin ( )-10 overproduction induces intracellular antiapoptotic proteins (Bcl-2 family proteins);
this increases the risk that self-reactive cells will persist during B-cell and T-cell development. This problem is compounded
by defective Fas-mediated apoptosis of mature cells. The result is the expansion of self-reactive cells that mediate autoimmunity. Proposed mechanism of autoimmunity in the autoimmune lymphoproliferative syndrome. Top.BTAPCBottom.IL
- Copyright ©2004 by the American College of Physicians
-
Ann Intern Med
April 6, 1999
vol. 130
no. 7
591-601